高级检索
当前位置: 首页 > 详情页

Bergenin Exerts Hepatoprotective Effects by Inhibiting the Release of Inflammatory Factors, Apoptosis and Autophagy via the PPAR-gamma Pathway

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Soochow Univ, Med Coll, Suzhou 215006, Peoples R China [2]Tongji Univ, Dept Gastroenterol, Shanghai Peoples Hosp 10, Sch Med, Shanghai 200072, Peoples R China [3]Shanghai Jiao Tong Univ, Dept Gastroenterol, Shanghai Tongren Hosp, Sch Med, Shanghai 200336, Peoples R China
出处:
ISSN:

关键词: hepatic ischemia reperfusion Bergenin reactive oxygen species apoptosis autophagy

摘要:
Objective: Hepatic ischemia reperfusion (IR) limits the development of liver transplantation technology. The aim of this study was to explore the protective effects of Bergenin on hepatic IR, particularly the elimination of reactive oxygen species (ROS) and activation of the peroxisome proliferators activated receptor gamma (PPAR-gamma) pathway. Methods: Initial experiments were performed to confirm the non-toxicity of Bergenin. Mice were randomly divided into sham, IR, and IR + Bergenin (10, 20 and 40 mg/kg) groups, and serum and tissue samples were obtained at 2, 8 and 24 h for detection of liver enzymes (ALT and AST), inflammatory factors (TNF-alpha, IL-6 and IL-1 beta), ROS, cell death markers (Bc1-2, Box, Beclin-1 and LC3) and related important pathways (PPAR-gamma, P38 MAPK, NF-kappa B p65 and JAK2/STAT1). Results: Bergenin reduced the release of ROS, down-regulated inflammatory factors, and inhibited apoptosis and autophagy. Additionally, expression of PPAR-gamma-related genes was increased and phosphorylation of P38 MAPK, NF-kappa B p65 and JAK2/STAT1-related proteins was decreased in Bergenin pre-treatment groups in a dose-dependent manner. Conclusion: Bergenin exerts hepatic protection by eliminating ROS, affecting the release of inflammatory factors, and influencing apoptosis- and autophagy-related genes via the PPAR-gamma pathway in this model of hepatic IR injury.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 药物化学 3 区 药学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 药物化学 2 区 药学
JCR分区:
出版当年[2018]版:
Q2 CHEMISTRY, MEDICINAL Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 CHEMISTRY, MEDICINAL Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Soochow Univ, Med Coll, Suzhou 215006, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Soochow Univ, Med Coll, Suzhou 215006, Peoples R China [2]Tongji Univ, Dept Gastroenterol, Shanghai Peoples Hosp 10, Sch Med, Shanghai 200072, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25463 今日访问量:0 总访问量:1498 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)